SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as traders discuss potential U.S.-China trade deal impacts and the strength of big tech companies like Apple, with community members weighing in on bullish and bearish signals. Debate centers around whether recent market behavior is indicative of a healthy consolidation or a looming correction, with some expressing concerns about potential risks in AI and regional banks. News of potential interest rate cuts, rising treasury yields, and key economic data releases are adding to the conversation.

Zcash is a decentralized and open-source cryptocurrency that offers privacy and selective transparency of transactions. Zcash payments are published on a public blockchain, but the sender, recipient, and amount of a transaction remain private.  Zcash is based on peer-reviewed cryptographic research, and built by a security-specialized engineering team on an open source platform based on Bitcoin Core's battle-tested codebase. Our improvement over Bitcoin is the addition of privacy. Zcash uses advanced cryptographic techniques, namely zero-knowledge proofs, to guarantee the validity of transactions without revealing additional information about them.  How Zcash works  Zcash encrypts the contents of shielded transactions. Since the payment information is encrypted, the protocol uses a novel cryptographic method to verify their validity.  Zcash uses a zero-knowledge proof construction called a zk-SNARK, developed by our team of experienced cryptographers based on recent breakthroughs in cryptography. These constructions allow the network to maintain a secure ledger of balances without disclosing the parties or amounts involved. Instead of publicly demonstrating spend-authority and transaction values, the transaction metadata is encrypted and zk-SNARKs are used to prove that nobody is cheating or stealing.  Zcash also enables users to send public payments which work similarly to Bitcoin. With the support for both shielded and transparent addresses, users can choose to send Zcash privately or publicly. Zcash payments sent from a shielded address to a transparent address reveal the received balance, while payments from a transparent address to a shielded address protect the receiving value.   Check out CoinBureau for guide on What is ZCash.

Zcash

Zcash is trending due to anticipation surrounding its upcoming halving in November 2025, which is expected to tighten supply and coincide with network upgrades. The community is actively discussing the potential market impact of the halving, drawing comparisons to Bitcoin's halving events, and some speculate ZEC could outperform other cryptos. Privacy narratives and potential for new all-time highs are also fueling interest.

SU Group Holdings Ltd. engages in the provision of security-related engineering services, and security guarding and screening services. It operates through the Security-Related Engineering Services and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.

SU Group Holdings Ltd. - Ordinary Shares - Class A

SU Group Holdings Ltd.

SUGP is trending due to community discussion around its low float, regained NASDAQ compliance, and a recently announced contract, drawing comparisons to other Hong Kong-based stocks that have experienced significant gains. Traders are also noting the high cost to borrow, speculating about a potential short squeeze. The company's expansion into EV infrastructure and AI-powered solutions is adding to the positive sentiment.

CTX is a governance token that powers and secures the Cryptex protocol. Holders of CTX can vote on protocol upgrades for TCAP as well as all future products within the Cryptex ecosystem.

Cryptex Finance

Cryptex Finance ($CTX) is trending due to community excitement around its low market cap and potential for significant gains, with some speculating about a move towards $5 or higher. Discussions also revolve around the upcoming launch of TCAP and the impact it may have on price action. Some traders are drawing parallels to similar low-float plays like $AVT and anticipating a potential breakout.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as investors discuss the potential of ivonescimab, particularly following trial data suggesting reduced cancer progression risk; the community is analyzing the drug's efficacy and overall survival benefits, while also considering potential regulatory hurdles and competition in the oncology market. Some traders point to insider buying as a bullish signal, while others express caution regarding the drug's performance in specific patient groups and the company's overall valuation. The conversation also includes speculation about potential partnerships and upcoming presentations of trial data.

Fuzzybear ($FUZZY) is a memecoin on the XRP Ledger (XRPL), created to honor the legacy of the well-known XRPL address ‘Fuzzybear,’ which famously placed a DEX order in 2014: 1 XRP for 1 BTC. The token embodies the spirit of decentralization and community-driven growth, focusing on fun, engagement, and organic expansion. With its unique narrative and strong community, Fuzzybear grows naturally as more supporters join the movement.

Fuzzybear

Fuzzybear ($FUZZY) is trending as community members highlight its connection to XRP and potential role within the XRP Ledger ecosystem, with some suggesting it could be the next big memecoin. Discussions also mention an upcoming event and the potential for exchange listings, fueling speculation and interest. Community members also note that David Schwartz, Ripple's CTO, recently joined a discussion about Fuzzybear on X.

Towns

$TOWNS is trending as community members actively discuss recent price movements and encourage others to join. Some users highlight potential for significant gains, while others speculate about exchange listings and future developments. The community references other trending tickers and possible connections to external entities, contributing to the heightened interest.

SSgA Active Trust - Technology Select Sector SPDR ETF

Technology Select Sector SPDR Fund

The technology sector, represented by XLK, is seeing mixed signals with potential tariff implications and leadership shifts impacting market sentiment. Community discussions revolve around whether current levels can be sustained, and if a broader market pullback is on the horizon, especially given earnings results from major tech companies and conflicting reports regarding trade policies. Despite some analysts remaining bullish, concerns about the sector's future performance are being actively discussed.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as the community rallies around its mission to revolutionize the cannabis market through cryptocurrency. Advocates emphasize its cultural significance and potential to flip big pharma, while drawing parallels to Bitcoin's disruptive impact. Community members are actively sharing links to the project's website and social media channels.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Root Inc. is garnering attention as community members discuss its potential, partnerships, and valuation relative to competitors like Progressive. Conversations revolve around whether the company can translate partnerships into substantial growth and if upcoming earnings will reflect this. Despite recent price declines, some investors remain optimistic, viewing it as an undervalued opportunity with long-term potential akin to early-stage Tesla or Hood.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SILK, MOR, AFBI, MGOL on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SILK, MOR, AFBI, MGOL on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SILK, MOR, AFBI, MGOL on Behalf of...

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Tender Offer Expiring August 2, 2024, of MorphoSys AG - MOR

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Tender Offer Expiring August 2, 2024, of MorphoSys AG - MOR SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Tender Offer Expiring...

MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market

MorphoSys AG (FSE: MOR; NASDAQ: MOR) today announced that it has formally notified the Nasdaq Stock Market of its intention to voluntarily delist its American Depositary Shares (ADSs) from the Nasdaq...

Kuehn Law Encourages DM, SHCR, MOR, and ALE Investors to Contact Law Firm

Kuehn Law Encourages DM, SHCR, MOR, and ALE Investors to Contact Law Firm Kuehn Law Encourages DM, SHCR, MOR, and ALE Investors to Contact Law Firm PR Newswire NEW YORK, July 8, 2024 NEW YORK, July...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BEST, MOR, HCP, SQSP on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BEST, MOR, HCP, SQSP on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BEST, MOR, HCP, SQSP on Behalf of...

MOR STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of MorphoSys AG Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of MorphoSys AG (NASDAQ: MOR) to Novartis for 68.00 per share in cash is fair to MorphoSys shareholders. Halper Sadeh...

MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys Minority Shareholders

MorphoSys AG (FSE: MOR; NASDAQ: MOR) today announced that the company has entered into a delisting agreement with Novartis BidCo AG and Novartis AG following the successful closing of the acquisition...

MorphoSys AG Reports First Quarter 2024 Financial Results

MorphoSys AG (FSE: MOR; NASDAQ: MOR) reports results for the first quarter of 2024. The proposed acquisition by Novartis is advancing steadily, and we continue to anticipate its closure in the first...

MorphoSys Says Novartis Deal Progressing Steadily Despite Safety Concerns Over Bone Marrow Cancer Drug, Pelabresib

MorphoSys faces safety concerns over pelabresib, a myelofibrosis treatment. Physicians report patients transitioning rapidly to acute myeloid leukemia. FDA alerted. Novartis acquisition proceeds...

Futures Rise, Yen Downgraded To Banana Republic Currency After Another Rollercoaster Session

Futures Rise, Yen Downgraded To Banana Republic Currency After Another Rollercoaster Session

 US equity futures swung between gains and losses and traded near session highs as US traders...

MorphoSys AG is a biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next generation of antibodies, which can be used to treat diseases and for research and diagnostics purposes. Numerous partnerships have already been entered into with well-known companies from the pharmaceutical and biotechnology sectors, such as Boehringer Ingelheim, Daiichi Sankyo, Merck & Co, Novartis, Pfizer, and Roche.

Morphosys AG - ADR

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

MOR
MorphoSys AG ADR

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest MOR News

MORMorphoSys AG ADR